Clinical Trial
Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group
- PMID: 84481
Item in Clipboard
Clinical Trial
Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group
Acta Derm Venereol.
1979.
Abstract
Prednimustine, a chlorambucil ester of prednisolone, was administered orally to 5 patients with mycosis fungoides in advanced tumour stage. Partial remission was obtained in 2 of the patients. However, we do not consider the agent to be particularly advantageous for the treatment of mycosis fungoides.
Similar articles
-
Epipodophyllotoxin (VP-16-213) in mycosis fungoides: A report from the Scandinavian mycosis fungoides study group.Acta Derm Venereol. 1979;59(1):84-7. Acta Derm Venereol. 1979. PMID: 84480 Clinical Trial.
-
Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.Acta Derm Venereol. 1980;60(6):542-4. Acta Derm Venereol. 1980. PMID: 6162347
-
Tumour stage of mycosis fungoides treated with bleomycin and methotrexate: report from the Scandinavian mycosis fungoides study group.Acta Derm Venereol. 1979;59(1):59-63. Acta Derm Venereol. 1979. PMID: 84469 Clinical Trial.
-
Photodynamic therapy in mycosis fungoides.Actas Dermosifiliogr. 2013 Jun;104(5):393-9. doi: 10.1016/j.adengl.2012.11.017. Epub 2013 May 9. Actas Dermosifiliogr. 2013. PMID: 23664412 Review. English, Spanish.
-
Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review.Eur J Dermatol. 2022 May 1;32(3):421-423. doi: 10.1684/ejd.2021.4126. Eur J Dermatol. 2022. PMID: 36065530 Free PMC article. No abstract available.